Robert Wenslow
16Patents
5h-index
79Co-inventors
65Inventor score
Filing activity: Sep 20, 2002 → Aug 28, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7326708B2 | Phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor | Human Necessities | 46 | Expired |
| US7145002B2 | Crystalline forms of carbapenem antibiotics and methods of preparation | Human Necessities | 30 | Expired |
| US7612072B2 | Amorphous form of a phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor | Human Necessities | 8 | Active |
| US7629470B2 | Formation of tetra-substituted enamides and stereoselective reduction thereof | Chemistry; Metallurgy | 7 | Expired |
| US9265756B2 | Crystalline forms of grapiprant | Chemistry; Metallurgy | 5 | Active |
| US7022841B2 | Process for making carbapenem compounds | Chemistry; Metallurgy | 4 | Expired |
| US8703779B2 | Preparation of crystalline forms of dihydropyrazolopyrimidinone | Human Necessities | 3 | Active |
| USRE40794E1 | Crystalline forms of carbapenem antibiotics and methods of preparation | General | 1 | Expired |
| US7700611B2 | Synthesis and crystalline forms of NPY5 antagonist | Human Necessities | 0 | Active |
| US9242917B2 | Crystal forms of a HCV protease inhibitor | Human Necessities | 0 | Active |
| US11267805B2 | Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) piperazine-1-yl)(1-hydroxycyclopropyl)methanone | Chemistry; Metallurgy | 0 | Active |
| US8129413B2 | Crystalline forms of MC4R agonist and process for synthesis | Chemistry; Metallurgy | 0 | Active |
| US10793554B2 | Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone | Chemistry; Metallurgy | 0 | Active |
| US8618112B2 | Crystalline forms of an inhibitor of 11-β-hydroxysteroid dehydrogenase type 1 | Human Necessities | 0 | Active |
| US8946269B2 | Crystalline forms of a factor Xa inhibitor | Chemistry; Metallurgy | 0 | Active |
| US9388186B2 | Preparation of crystalline forms of dihydropyrazolopyrimidinone | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.